Cherrydale Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,588
Closed -$227K 76
2024
Q2
$227K Buy
+1,588
New +$227K 0.1% 53